Results 161 to 170 of about 34,694 (215)

Eravacycline monotherapy and combination therapy against KPC-2- and NDM-1-co- producing <i>Klebsiella pneumoniae</i>: <i>in vitro</i> and <i>in vivo</i> activity analysis. [PDF]

Front Microbiol
Zhao X, Wang J, Deng X, Shi M, Song S, Zhao S, Sun J, Ma Y, Zhu W, Jiang F, Tong J, Kang H.   +11 more
europepmc   +1 more source

Dissemination of KPC-2-producing carbapenem-resistant <i>Klebsiella pneumoniae</i> ST792 in Southern China. [PDF]

Front Microbiol
Wan C, Li M, Gao H, Zhou P, Wang B, Shi J, Shen L, Han W, Yuan X, Lv J, Huang Y, Zhou Y, Yu F.   +12 more
europepmc   +1 more source

Impact of the double deletion ΔG242-T243 in KPC-2 in the effectiveness of ceftazidime-avibactam and imipenem-relebactam. [PDF]

Antimicrob Agents Chemother
Brunetti F, Gutkind G, Gao L, Haider S, Bonomo RA, Power P.   +5 more
europepmc   +1 more source

Comparison of CRISPR-Cas9, CRISPR-Cas12f1, and CRISPR-Cas3 in eradicating resistance genes KPC-2 and IMP-4. [PDF]

Microbiol Spectr
Huang J, Ding K, Chen J, Fan J, Huang L, Qiu S, Wang L, Du X, Wang C, Pan H, Yuan Z, Liu H, Song H.   +12 more
europepmc   +1 more source

Co-Production of KPC-2 and NDM-5 in a Carbapenem-Resistant <i>Klebsiella Pneumoniae</i> Clinical Isolate: Genetic Insights and Risks. [PDF]

Infect Drug Resist
Xia Y, Zhou P, Gao H, Wu X, Zhou Y, Han W, Wan C, Wu Q, Ding J, Yu F.   +9 more
europepmc   +1 more source

Emergence of co-resistance to imipenem/relebactam and ceftazidime/avibactam in clinical <i>Klebsiella pneumoniae</i> ST11 clone due to KPC-2 N132S and CTX-M-65 S130G/P167S substitutions. [PDF]

Antimicrob Agents Chemother
Fu Y, Zhang Y, Zhao J, Xie J, Kong H, Yang T, Chen W, Xu M.   +7 more
europepmc   +1 more source

TEM-15 and TEM-17, rare ESBLs re-emerging in a KPC-2-producing <i>Klebsiella quasipneumoniae</i> subsp. <i>similipneumoniae</i> ST2131 from wastewater, Brazil. [PDF]

New Microbes New Infect
Furlan JPR, Bueno GC, Sousa-Carmo RR, Silva RLO, Barbosa MRF, Sato MIZ, Lincopan N, Schenkman S.   +7 more
europepmc   +1 more source

Transcriptomic Insights into Adaptive Strategies of <i>Klebsiella pneumoniae</i> Co-Producing KPC-2 and NDM-5 Carbapenemases Under Meropenem Stress. [PDF]

Infect Drug Resist
Dai L, Zhang H, Cao Y, Ding J, Tang J, Xiao Z, Chen Z, Ling J, Zou M, Cao X, Lin L, Xu Z, Liu W, Chen D, Yuan P.   +14 more
europepmc   +1 more source

Evaluation of ceftazidime/avibactam in combination with colistin against KPC-2-producing <i>Klebsiella pneumoniae</i> in static and dynamic time-kill experiments. [PDF]

JAC Antimicrob Resist
Allander L, Vikdahl E, Chatzopoulou M, O'Jeanson A, Sandegren L, Lagerbäck P, Tängdén T.   +6 more
europepmc   +1 more source

Global emergence of Carbapenem-resistant Hypervirulent Klebsiella pneumoniae driven by an IncFII_K34 KPC-2 plasmid. [PDF]

EBioMedicine
Jiang J, Wang L, Hu Y, Chen X, Li P, Zhang J, Zhang Y, Su J, Xu X, Xiao Y, Liu Z, Yu Y, Gao H, Doi Y, van Duin D, Fowler VG, Chen L, Wang M.   +17 more
europepmc   +1 more source